Hammerschmidt, Tatiane G.
Guerreiro, Gilian B.
Donida, Bruna
Raabe, Marco
Kessler, Rejane G.
Ferro, Matheus B.
Moura, Dinara J.
Giugliani, Roberto
Vargas, Carmen R.
Funding for this research was provided by:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Fundo de Incentivo à Pesquisa e Eventos (FIPE/HCPA). (2018-0648)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (430443/2018-8)
Article History
Received: 20 December 2022
Accepted: 8 February 2023
First Online: 16 February 2023
Declarations
:
: We performed this study in line with the principles of the Declaration of Helsinki and the project was approved by the Research Ethics Committee of the Hospital de Clínicas de Porto Alegre (CEP/HCPA) under number 2018–0648.
: Informed consent was obtained from all individual participants, or legal guardians, included in the study.
: RG received speaker honoraria, travel grants, educational grants, and/or investigator fees from Actelion, Amicus, Armagen, BioMarin, Inventiva, JCR Pharmaceuticals, Lysogene, RegenxBio, Sangamo, Sanofi-Genzyme, Takeda, Sobi and Ultragenyx. All other authors declare that they have no conflict of interest.